mGluR2 Activators and mGluR5 Blockers Advancing in the Clinic for Major CNS Disorders

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annual Reports in Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-12-396492-2.00006-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist.

  2013cited by this paper
• CNS distribution of metabotropic glutamate 2 and 3 receptors: transgenic mice and [³H]LY459477 autoradiography.

  2013cited by this paper
• The role of metabotropic glutamate receptors in addiction: evidence from preclinical models.

  2012cited by this paper
• Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia.

  2012cited by this paper
• From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

  2012cited by this paper
• Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor.

  2012cited by this paper
• Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.

  2012cited by this paper
• Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators

  2011cited by this paper
• 3-(Pyridin-2-yl-ethynyl)benzamide metabotropic glutamate receptor 5 negative allosteric modulators: hit to lead studies.

  2011cited by this paper
• Exciting Times beyond the Brain: Metabotropic Glutamate Receptors in Peripheral and Non-Neural Tissues

  2011cited by this paper
• Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056

  2011cited by this paper
• Treatment of Levodopa-Induced Dyskinesias : Results of 2 Randomized Controlled Trials

  2011cited by this paper
• New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of N-propyl-8-chloro-6-substituted isoquinolones.

  2011cited by this paper
• (3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu(5): Discovery of a new tool compound with activity in the OSS mouse model of addiction.

  2011cited by this paper
• Preface (New Research Frontiers and Advances in Drug Addiction)

  2011cited by this paper
• AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome.

  2011cited by this paper
• Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats

  2011cited by this paper
• Recent advances in the design and development of novel negative allosteric modulators of mGlu(5).

  2011cited by this paper
• Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential.

  2011cited by this paper
• mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutic agents.

  2011cited by this paper
• Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.

  2011cited by this paper
• 6-Aryl-3-pyrrolidinylpyridines as mGlu5 receptor negative allosteric modulators.

  2011cited by this paper
• Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on l-DOPA-induced dyskinesia

  2011cited by this paper
• Study of Novel Selective mGlu2 Agonist in the Temporo-Ammonic Input to CA1 Neurons Reveals Reduced mGlu2 Receptor Expression in a Wistar Substrain with an Anxiety-Like Phenotype

  2011cited by this paper
• Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5).

  2011cited by this paper
• Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile.

  2011cited by this paper
• Dimers and beyond: The functional puzzles of class C GPCRs.

  2011cited by this paper
• Progress in the developement of positive allosteric modulators of the metabotropic glutamate receptor 2.

  2011cited by this paper
• Metabotropic glutamate receptors: from the workbench to the bedside.

  2011cited by this paper
• A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia

  2011cited by this paper
• Potent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series.

  2011cited by this paper
• CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor

  2011cited by this paper
• Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats.

  2011cited by this paper
• 1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosis.

  2011cited by this paper
• Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 Receptor.

  2010cited by this paper
• LY-2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY-404039 for the potential treatment of schizophrenia.

  2010cited by this paper
• Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs.

  2010cited by this paper
• The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2.

  2010cited by this paper
• Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity

  2010cited by this paper
• Functional crosstalk between GPCRs: with or without oligomerization.

  2010cited by this paper
• Effects of a Positive Allosteric Modulator of Group II Metabotropic Glutamate Receptors, LY487379, on Cognitive Flexibility and Impulsive-Like Responding in Rats

  2010cited by this paper
• Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine?

  2010cited by this paper
• Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor.

  2010cited by this paper
• Metabotropic glutamate receptors: physiology, pharmacology, and disease.

  2010cited by this paper
• The identification of novel orally active mGluR5 antagonist GSK2210875.

  2010cited by this paper
• 3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts.

  2010cited by this paper
• The glutamate homeostasis hypothesis of addiction

  2009cited by this paper
• Mutagenesis and Molecular Modeling of the Orthosteric Binding Site of the mGlu2 Receptor Determining Interactions of the Group II Receptor Antagonist 3H‐HYDIA

  2009cited by this paper
• Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia

  2009cited by this paper
• Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture.

  2009cited by this paper
• Efficacy and Tolerability of an mGlu2/3 Agonist in the Treatment of Generalized Anxiety Disorder

  2008cited by this paper
• Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.

  2007cited by this paper
• Synthesis and metabotropic glutamate receptor activity of S-oxidized variants of (-)-4-amino-2-thiabicyclo-[3.1.0]hexane-4,6-dicarboxylate: identification of potent, selective, and orally bioavailable agonists for mGlu2/3 receptors.

  2007cited by this paper
• Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

  2007cited by this paper
• Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

  2005cited by this paper
• Metabotropic glutamate receptors in the basal ganglia motor circuit

  2005cited by this paper
• Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740

  2005cited by this paper
• Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans

  2003cited by this paper
• G Protein-Coupled Receptor Allosterism and Complexing

  2002cited by this paper
• Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites.

  2001cited by this paper
• Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors.

  1998cited by this paper
• Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain

  1995cited by this paper
• The metabotropic glutamate receptors: structure and functions.

  1995cited by this paper

• Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates

  2020cites this paper
• Epoxide Syntheses and Ring-Opening Reactions in Drug Development

  2020cites this paper
• An Introduction to the CNS Section of Volume 7: Recent Approvals and Advances in CNS Drug Discovery

  2017cites this paper
• Gold-Catalyzed Intermolecular, anti-Markovnikov Hydroarylation of Methylenecyclopropanes with Indoles.

  2016cites this paper
• Metabotropic glutamate receptor 5-negative allosteric modulators for the treatment of psychiatric and neurological disorders (2009-July 2013).

  2013cites this paper